Literature DB >> 23143001

Changes in the biological characteristics of glioma cancer stem cells after serial in vivo subtransplantation.

Ga-Yeong Shin1, Jin-Kyoung Shim, Ji-Hyun Lee, Hye-Jin Shin, Su-Jae Lee, Yong-Min Huh, Eui-Hyun Kim, Eun-Kyung Park, Se-Hoon Kim, Jong Hee Chang, Dong-Seok Kim, Yong-Kil Hong, Sun Ho Kim, Seok-Gu Kang, Frederick F Lang.   

Abstract

PURPOSE: Currently, the interaction between the niche and glioma cancer stem cells (gCSCs) is gaining attention. However, there are few studies concerned with the effects of repeated exposure to a new microenvironment on gCSCs characteristics. In this study, serial in vivo subtransplantation was performed to create a new microenvironment. We evaluated and compared the biological characteristics of gCSCs after serial in vivo subtransplantation.
METHODS: We cultured gCSCs from human glioma specimens according to cultured gliomasphere methods. The isolated gCSCs were termed zero-generation gCSCs (G0-gCSCs). By subsequent serial subtransplantation, we obtained first-generation gCSCs (G1-gCSCs) and second-generation gCSCs (G2-gCSCs). We evaluated and compared the biological characteristics of G0-gCSCs, G1-gCSCs, and G2-gCSCs. The in vitro characteristics included the morphology, surface marker profiles, and neural differentiation capacity and the in vivo characteristics was the survival of mice xenografts. Additionally, brain sections were analyzed using PCNA, TUNEL, and CD31 staining.
RESULTS: We observed no significant differences in the in vitro characteristics of G0-gCSCs, G1-gCSCs, and G2-gCSCs. However, the survival time of mice glioma xenografts was significantly decreased upon serial subtransplantation. In addition, immunohistochemical analyses showed that the number of TUNEL(+) cells was significantly decreased while the number of CD31(+) cells was significantly increased with serial in vivo subtransplantation.
CONCLUSIONS: There were significant in vivo biological changes in gCSCs upon serial in vivo subtransplantation, which were shorter xenograft survival, increased angiogenesis, and decreased apoptosis. This study suggests that the repeated exposure to new microenvironments may affect the biological changes in gCSCs in vivo.

Entities:  

Mesh:

Substances:

Year:  2012        PMID: 23143001     DOI: 10.1007/s00381-012-1963-x

Source DB:  PubMed          Journal:  Childs Nerv Syst        ISSN: 0256-7040            Impact factor:   1.475


  42 in total

Review 1.  The stem-cell niche theory: lessons from flies.

Authors:  Haifan Lin
Journal:  Nat Rev Genet       Date:  2002-12       Impact factor: 53.242

2.  Radiation resistance and stem-like cells in brain tumors.

Authors:  Dolores Hambardzumyan; Massimo Squatrito; Massimo Squartro; Eric C Holland
Journal:  Cancer Cell       Date:  2006-12       Impact factor: 31.743

Review 3.  Glioblastoma therapy: going beyond Hercules Columns.

Authors:  Annunziato Mangiola; Carmelo Anile; Angelo Pompucci; Gennaro Capone; Luigi Rigante; Pasquale De Bonis
Journal:  Expert Rev Neurother       Date:  2010-04       Impact factor: 4.618

4.  Frizzled 4 regulates stemness and invasiveness of migrating glioma cells established by serial intracranial transplantation.

Authors:  Xun Jin; Hee-Young Jeon; Kyeung Min Joo; Jun-Kyum Kim; Juyoun Jin; Sung Hak Kim; Bong Gu Kang; Samuel Beck; Se Jeong Lee; Joong Kyu Kim; Ae-Kyung Park; Woong-Yang Park; Yun-Jaie Choi; Do-Hyun Nam; Hyunggee Kim
Journal:  Cancer Res       Date:  2011-03-01       Impact factor: 12.701

Review 5.  Tumour stem cells and drug resistance.

Authors:  Michael Dean; Tito Fojo; Susan Bates
Journal:  Nat Rev Cancer       Date:  2005-04       Impact factor: 60.716

6.  Brain tumor stem cells maintain overall phenotype and tumorigenicity after in vitro culturing in serum-free conditions.

Authors:  Einar Osland Vik-Mo; Cecilie Sandberg; Havard Olstorn; Mercy Varghese; Petter Brandal; Jon Ramm-Pettersen; Wayne Murrell; Iver Arne Langmoen
Journal:  Neuro Oncol       Date:  2010-09-14       Impact factor: 12.300

7.  Tumor environment dictates medulloblastoma cancer stem cell expression and invasive phenotype.

Authors:  Borhane Annabi; Shanti Rojas-Sutterlin; Carl Laflamme; Marie-Paule Lachambre; Yannève Rolland; Hervé Sartelet; Richard Béliveau
Journal:  Mol Cancer Res       Date:  2008-06       Impact factor: 5.852

Review 8.  Malignant astrocytic glioma: genetics, biology, and paths to treatment.

Authors:  Frank B Furnari; Tim Fenton; Robert M Bachoo; Akitake Mukasa; Jayne M Stommel; Alexander Stegh; William C Hahn; Keith L Ligon; David N Louis; Cameron Brennan; Lynda Chin; Ronald A DePinho; Webster K Cavenee
Journal:  Genes Dev       Date:  2007-11-01       Impact factor: 11.361

Review 9.  Cancer stem cells in pediatric brain tumors.

Authors:  Joseph L Lasky; Meeryo Choe; Ichiro Nakano
Journal:  Curr Stem Cell Res Ther       Date:  2009-12       Impact factor: 3.828

10.  A clinically relevant orthotopic xenograft model of ependymoma that maintains the genomic signature of the primary tumor and preserves cancer stem cells in vivo.

Authors:  Litian Yu; Patricia A Baxter; Horatiu Voicu; Sivashankarappa Gurusiddappa; Yijue Zhao; Adekunle Adesina; Tsz-Kwong Man; Qin Shu; Yu-Jing Zhang; Xiu-Mei Zhao; Jack M Su; Lazlo Perlaky; Robert Dauser; Murali Chintagumpala; Ching C Lau; Susan M Blaney; Pulivarthi H Rao; Hon-Chiu Eastwood Leung; Xiao-Nan Li
Journal:  Neuro Oncol       Date:  2010-02-08       Impact factor: 12.300

View more
  6 in total

1.  Existence of glioma stroma mesenchymal stemlike cells in Korean glioma specimens.

Authors:  Young Goo Kim; Soyoun Jeon; Ga-Yeong Sin; Jin-Kyoung Shim; Bo-Kyung Kim; Hye-Jin Shin; Ji-Hyun Lee; Yong-Min Huh; Su-Jae Lee; Eui-Hyun Kim; Eun Kyung Park; Se-Hoon Kim; Jong Hee Chang; Dong Seok Kim; Sun Ho Kim; Yong-Kil Hong; Seok-Gu Kang; Frederick F Lang
Journal:  Childs Nerv Syst       Date:  2012-12-29       Impact factor: 1.475

2.  Isolation of tumor spheres and mesenchymal stem-like cells from a single primitive neuroectodermal tumor specimen.

Authors:  Jiyong Kwak; Hye-Jin Shin; Se-Hoon Kim; Jin-Kyoung Shim; Ji-Hyun Lee; Yong-Min Huh; Eui-Hyun Kim; Eun-Kyung Park; Jong Hee Chang; Sun Ho Kim; Yong-Kil Hong; Dong-Seok Kim; Su-Jae Lee; Seok-Gu Kang
Journal:  Childs Nerv Syst       Date:  2013-06-28       Impact factor: 1.475

3.  Prognostic value of glioma cancer stem cell isolation in survival of primary glioblastoma patients.

Authors:  Byung Ho Kong; Ju Hyung Moon; Yong-Min Huh; Jin-Kyoung Shim; Ji-Hyun Lee; Eui-Hyun Kim; Jong Hee Chang; Dong-Seok Kim; Yong-Kil Hong; Sun Ho Kim; Su-Jae Lee; Seok-Gu Kang
Journal:  Stem Cells Int       Date:  2014-12-11       Impact factor: 5.443

4.  Success of tumorsphere isolation from WHO grade IV gliomas does not correlate with the weight of fresh tumor specimens: an immunohistochemical characterization of tumorsphere differentiation.

Authors:  Kyoung Su Sung; Jin-Kyoung Shim; Ji-Hyun Lee; Se Hoon Kim; Sohee Park; Tae-Hoon Roh; Ju Hyung Moon; Eui-Hyun Kim; Sun Ho Kim; Su Jae Lee; Yong Min Huh; Seok-Gu Kang; Jong Hee Chang
Journal:  Cancer Cell Int       Date:  2016-09-27       Impact factor: 5.722

5.  Heterotypic mouse models of canine osteosarcoma recapitulate tumor heterogeneity and biological behavior.

Authors:  Milcah C Scott; Hirotaka Tomiyasu; John R Garbe; Ingrid Cornax; Clarissa Amaya; M Gerard O'Sullivan; Subbaya Subramanian; Brad A Bryan; Jaime F Modiano
Journal:  Dis Model Mech       Date:  2016-11-03       Impact factor: 5.758

6.  Failure of a patient-derived xenograft for brain tumor model prepared by implantation of tissue fragments.

Authors:  Kyung-Min Kim; Jin-Kyoung Shim; Jong Hee Chang; Ji-Hyun Lee; Se-Hoon Kim; Junjeong Choi; Junseong Park; Eui-Hyun Kim; Sun Ho Kim; Yong-Min Huh; Su-Jae Lee; Jae-Ho Cheong; Seok-Gu Kang
Journal:  Cancer Cell Int       Date:  2016-06-10       Impact factor: 5.722

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.